We Accelerate Discovery

Creative People - Creative IdeasLearn More


Reporter - Search Portfolios of Funded Research

Subscribe to the NIH Roadmap E-mail List

  • Highlights

    SINGLE ANIMAL TO
    HUMAN TRANSMISSION
    EVENT RESPONSIBLE FOR
    2014 EBOLA OUTBREAK

    Click for More >>

    Double Meaning: Researchers Discover “Hidden Code” in Genes

  • Highlights

    MOLECULAR LIBRARIES
    DISCOVERY LEADS TO
    CLINICAL TRIAL

    Click for More >>

    Molecular Libraries Discovery Lead to Clinical Trial

  • Highlights

    FEATURED VIDEO:
    EMERGING DISEASE OR
    EMERGING DIAGNOSIS?

    Click for More >>

    FEATURED VIDEO: EMERGING DISEASE OR EMERGING DIAGNOSIS?

  • Highlights

    REST: The Difference
    between Destruction
    and Protection
    of the Brain

    Click for More >>

    REST: The Difference between Destruction and Protection of the Brain

  • Highlights

    EXTRACELLULAR RNA SHOWS
    PROMISE IN TREATING MULTIPLE
    SCLEROSIS

    Click for More >>

    Extracellular RNA Shows Promise in Treating Multiple Sclerosis

    NEW! Stimulating Peripheral Activity to Relieve Conditions (SPARC) Issues Three Requests for Information!

    The Common Fund SPARC program aims to provide the scientific foundation required to catalyze the development of new and/or more efficacious therapies utilizing closed-loop neuromodulation to modulate end-organ system function. To this end, the SPARC program recently released three Requests for Information seeking input from the biomedical research community, potential biotechnology and pharmaceutical company partners, and other members of the public.

    To read about the new SPARC RFIs and learn more about the program, visit the SPARC website here.

    NEW! Common Fund Diversity Program Awards Announced

    The NIH has announced approximately $31 million to develop new approaches that engage researchers, including those from backgrounds underrepresented in biomedical sciences, and prepare them to thrive in the NIH-funded workforce.

    Read the press release

    See the Funded Research

    NEW! Funding Opportunity for the Early Independence Award (EIA) Initiative: http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-14-004.html.

    Letters of Intent are due on December 30, 2014. The application due date is January 30, 2015.  Learn more about the EIA program here!

    NEW! The NIH Common Fund Glycoscience Program is focused on creating new methodologies and resources to study glycans and to develop these resources so they may be more easily understood and accessed by the broader biomedical research community. The Glycoscience Program has recently released four new Funding Opportunity Announcements (FOAs).

    To read about the new Glycoscience FOAs, visit the Glycoscience website here.

    NEW!  Funding Opportunity Announcement: Model Organisms Screening Center for the Undiagnosed Diseases Network (UDN) (U54)

    Funding Opportunity Announcement (FOA) to establish a Model Organisms Screening Center for evaluating the pathogenicity and function of approximately 200 gene variants per year identified through the Undiagnosed Disease Network (UDN).  Responsive applications will propose to establish a screening platform involving at a minimum, Drosophila and zebrafish models. The screening pipeline may include additional small animal models or cell-based assays. For more information, visit here.

    NEW! 4D Nucleome Program Issues Six Funding Opportunity Announcements!

    The Common Fund 4D Nucleome program aims to understand the principles underlying nuclear organization in space and time, the role nuclear organization plays in gene expression and cellular function, and how changes in nuclear organization affect normal development as well as various diseases. To read about the new 4D Nucleome Funding Opportunity Announcements, visit the 4D Nucleome website here.

     

    The NIH Common Fund is managed by the Office of Strategic Coordination, part of the Division of Program Coordination, Planning and Strategic Initiatives (DPCPSI).

    Read more >